ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 105 filers reported holding ARATANA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $19,279,000 | +52.0% | 3,736,334 | +6.1% | 0.00% | 0.0% |
| Q1 2019 | $12,682,000 | -43.0% | 3,522,804 | -2.9% | 0.00% | 0.0% |
| Q4 2018 | $22,249,000 | +10.8% | 3,629,595 | +5.5% | 0.00% | 0.0% |
| Q3 2018 | $20,087,000 | +41.1% | 3,439,584 | +2.7% | 0.00% | 0.0% |
| Q2 2018 | $14,231,000 | +7.5% | 3,348,240 | +11.5% | 0.00% | 0.0% |
| Q1 2018 | $13,244,000 | -17.8% | 3,003,036 | -2.0% | 0.00% | 0.0% |
| Q4 2017 | $16,118,000 | -15.6% | 3,064,115 | -1.6% | 0.00% | 0.0% |
| Q3 2017 | $19,088,000 | -11.9% | 3,113,869 | +4.0% | 0.00% | 0.0% |
| Q2 2017 | $21,656,000 | +54.3% | 2,995,290 | +13.1% | 0.00% | 0.0% |
| Q1 2017 | $14,038,000 | +60934.8% | 2,649,101 | +82144.7% | 0.00% | – |
| Q4 2016 | $23,000 | -34.3% | 3,221 | -14.8% | 0.00% | – |
| Q3 2016 | $35,000 | +66.7% | 3,779 | +14.2% | 0.00% | – |
| Q2 2016 | $21,000 | +90.9% | 3,310 | +79.9% | 0.00% | – |
| Q1 2016 | $11,000 | +175.0% | 1,840 | +184.8% | 0.00% | – |
| Q4 2015 | $4,000 | -20.0% | 646 | 0.0% | 0.00% | – |
| Q3 2015 | $5,000 | -50.0% | 646 | 0.0% | 0.00% | – |
| Q2 2015 | $10,000 | -16.7% | 646 | -15.2% | 0.00% | – |
| Q1 2015 | $12,000 | -14.3% | 762 | 0.0% | 0.00% | – |
| Q4 2014 | $14,000 | +75.0% | 762 | 0.0% | 0.00% | – |
| Q3 2014 | $8,000 | -11.1% | 762 | +26.2% | 0.00% | – |
| Q2 2014 | $9,000 | – | 604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|